Exclusive: Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual
Pfizer Inc (PFE.N) said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face interactions with sales people after the COVID-19 pandemic ends.
S&P 500, Dow hit record highs on 1st trading day of 2022
The S&P 500 (.SPX) and Dow Jones Industrial Average (.DJI) posted closing record highs on the first trading day of the year on Monday, helped by gains in Tesla Inc (TSLA.O)and bank shares.
Pfizer shares hit record high with COVID-19 vaccine stocks on a tear
Shares of Pfizer Inc (PFE.N) hit a record high on Tuesday for the first time in more than 20 years as shares of COVID-19 vaccine makers have surged amid rising coronavirus cases in the United States.
BioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far
BioNTech and partner Pfizer (PFE.N) have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca (AZN.L), the German biotech group said on Monday.
AstraZeneca COVID-19 sales jump as drugmaker navigates vaccine challenges
Second-quarter sales of AstraZeneca’s (AZN.L) COVID-19 vaccine more than tripled to $894 million from the first quarter, but the drugmaker on Thursday again delayed its U.S. application for approval as it gathers more data for submissions.
U.S. to donate 500 million Pfizer doses to poor nations
The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer (PFE.N) coronavirus vaccine to some of the world’s poorest countries, it said on Thursday, urging other G7 nations to follow suit.
U.S. stocks end lower ahead of inflation report
Wall Street ended a see-saw session lower on Wednesday as market participants awaited inflation data for clues as to when the U.S. Federal Reserve might tighten its dovish monetary policy.
UPS shares fall as investors fret over post-pandemic growth plan
United Parcel Service Inc (UPS.N) shares fell as much as 6% on Wednesday as the company known for delivering everything from Amazon.com packages to coronavirus vaccines forecast disappointing post-pandemic U.S. margins.
